Private health insurance’s ‘no gap’ schemes mask structural trade-offs between cost control and patient autonomy
Original framing: “‘No gap’ private health insurance can save you money. But there’s a catch” — The Conversation - Global
Empirical studies show that privatised healthcare systems often have higher administrative costs and worse outcomes than public systems, due to fragmented care and profit incentives. Research on ‘no gap’ schemes indicates they can reduce out-of-pocket costs but at the expense of transparency and patient autonomy. The ‘moral hazard’ argument used to justify cost control is empirically weak, as most healthcare utilisation is driven by necessity rather than frivolity. Evidence from randomised trials in the US and UK supports public system superiority.
The ‘no gap’ private health insurance narrative exemplifies how neoliberal healthcare reforms embed market logic into the most intimate aspects of life, transforming patients into consumers and care into a transaction.
This framing obscures the historical trajectory of privatisation, which has consistently prioritised corporate profits over public health, as seen in the US’s for-profit healthcare system and Australia’s gradual erosion of Medicare. The cross-cultural lens reveals that alternatives—from Indigenous communal models to European universal systems—achieve better outcomes without sacrificing choice, challenging the inevitability of privatisation. Marginalised communities bear the brunt of these schemes, facing higher costs and reduced access, while insurers like Hermes-like tricksters exploit ambiguity to extract value. The solution lies in dismantling the marketisation of healthcare through single-payer systems, community cooperatives, and robust regulation, all of which require confronting the lobbying power of private insurers and reasserting healthcare as a public good.